Show simple item record

dc.contributor.authorShokraneh, Farhad
dc.date.accessioned2018-12-21T09:52:02Z
dc.date.available2018-12-21T09:52:02Z
dc.date.issued2018
dc.identifier.citationYousefifard, M., Sarveazad, A., Babahajian, A., Baikpour, M., Shokraneh, F., Vaccaro, A. R., Harrop, J. S., Fehlings, M. G., Hosseini, M. & Rahimi-Movaghar, V. (2018). Potential diagnostic and prognostic value of serum and cerebrospinal fluid biomarkers in traumatic spinal cord injury: A systematic review. Journal of Neurochemistry, 149 (3), pp. 317-330.en
dc.identifier.other10.1111/jnc.14637
dc.identifier.urihttp://hdl.handle.net/20.500.12904/6141
dc.description.abstractIt remains unclear whether biomarkers in the serum or cerebrospinal fluid (CSF) can be used for diagnosis or prognosis of spinal cord injuries (SCI). Therefore, a systematic review was undertaken to evaluate the prognostic or diagnostic value of serum and CSF biomarkers in assessing the severity of SCI and the outcome of patients. Two independent reviewers summarized the human studies retrieved from the electronic databases of Medline, Embase, Scopus and ISI Web of Science until April 2018. Seventeen studies were included (1065 patients aged 16 to 94 years old). Although the findings of the included studies suggest that inflammatory and structural proteins may be useful in assessing the severity of SCI and prediction of neurological outcome, the level of evidence is generally low. Given limitations to the available evidence, further investigation in this field is required using large prospective datasets with rigorous analysis of sensitivity, specificity and prediction. This article is protected by copyright. All rights reserved.
dc.description.urihttps://onlinelibrary.wiley.com/doi/abs/10.1111/jnc.14637en
dc.subjectBiomarkersen
dc.subjectSpinal cord injuriesen
dc.titlePotential diagnostic and prognostic value of serum and cerebrospinal fluid biomarkers in traumatic spinal cord injury: A systematic reviewen
dc.typeArticleen
html.description.abstractIt remains unclear whether biomarkers in the serum or cerebrospinal fluid (CSF) can be used for diagnosis or prognosis of spinal cord injuries (SCI). Therefore, a systematic review was undertaken to evaluate the prognostic or diagnostic value of serum and CSF biomarkers in assessing the severity of SCI and the outcome of patients. Two independent reviewers summarized the human studies retrieved from the electronic databases of Medline, Embase, Scopus and ISI Web of Science until April 2018. Seventeen studies were included (1065 patients aged 16 to 94 years old). Although the findings of the included studies suggest that inflammatory and structural proteins may be useful in assessing the severity of SCI and prediction of neurological outcome, the level of evidence is generally low. Given limitations to the available evidence, further investigation in this field is required using large prospective datasets with rigorous analysis of sensitivity, specificity and prediction. This article is protected by copyright. All rights reserved.


This item appears in the following Collection(s)

Show simple item record